Stelis Biopharma

#Reminder: All future updates will now be shared on OneSource page. As we move forward with our journey as OneSource, we invite you to stay connected and follow us on our new LinkedIn page for the latest insights and updates: https://lnkd.in/gZFezWsJ #FollowOneSource #OneSourceCDMO #CDMO 

We’ve transitioned to a new OneSource LinkedIn page, and we want to bring you along on this exciting journey. Join us on our new LinkedIn page to stay updated about OneSource Don’t miss out - follow OneSource now. https://lnkd.in/gZFezWsJ #FollowOneSource #OneSourceCDMO #CDMO

#PressRelease - We are pleased to announce that OneSource Specialty Pharma Limited (formerly known as Stelis Biopharma Limited) has received commitments for fundraising of INR 8,010 mn (~USD 95 mn) from marquee domestic and foreign institutional investors and family offices, in the pre-listing round.   For more details, click the following link - https://lnkd.in/gJpiNE4c #OneSourceCDMO #CDMO

Insightful presentation at the Festival of Biologics. Yesterday, Prateek Gupta, PhD delivered a compelling presentation on "5 Elements for Successful Biologics/Biosimilars Development – The CDMO Perspective" He shared key strategies that enable CDMOs to transform into true value partners for biologics development. A big thank you to everyone who joined the session and visited our booth (#904) Stay tuned for more details from the presentation . It’s been a productive time connecting with experts and innovators in the biologics space. We look forward to building on these insights and partnerships. #FestivalOfBiologics #CDMO #OneSourceCDMO

Meet our experts at Festival of Biologics | Booth 904 Stop by Booth 904 to discover how we can accelerate your biologics journey from concept to commercial success. Prateek Gupta, PhD will be presenting “5 Elements for Successful Biologics/Biosimilars Development – The CDMO Perspective” on October 15 at 14:20. Learn key strategies that help CDMOs transform into true value partners for biologics development. To schedule a meeting, email us at [email protected] Explore more: www.onesourcecdmo.com #FestivalOfBiologics #OneSourceCDMO #Biologics

Thank you for visiting OneSource at #CPHI Milan 2024 It's been a highly productive event, full of engaging conversations and inspiring partnerships. We are grateful to everyone who stopped by our booth, shared insights, and explored how OneSource can support your CDMO needs. As we wrap up an exciting three days, we look forward to continuing these discussions and driving innovation together. Let's stay connected and partner for success. #OneSource #CPHI2024 #Partnerships #CDMO

Visit us at CPHI Milan, Booth 5C33 from 8 - 10 October and discover how we’re redefining partnership with end-to-end capabilities and a customer-first mindset. Let’s unlock the future of biopharma together Explore more: www.onesourcecdmo.com OneSource #OneSourceLaunch #CPHI2024 #CDMO

Exciting News from CPHI Milan! We’re pleased to announce the official launch of OneSource, our new brand identity. Visit us at Booth #5C33 to learn more about our end-to-end #CDMO capabilities and how we are driving growth in the biopharma space. Read our press release: https://lnkd.in/g27Jjtyy Explore more at: www.OneSourceCDMO.com #OneSourceLaunch #BrandLaunch #CDMO #CPHI2024 #DrugDeviceCombinations #Biologics #SoftGelCapsules

Exciting times ahead at OneSource We’re launching a new chapter in our journey. Catch us at #CPHI2024 Milan for the unveiling of our new identity. Stay tuned. #CDMO #OneSourceCDMO

At Stelis, we specialize in providing seamless end-to-end services across drug-device combinations, complex injectables, biologics and softgel technologies. From development to commercial supply, we enable our partners to accelerate their journey from concept to market with efficiency and excellence. Our advanced cGMP facilities, global compliance standards, and deep technical expertise help drive innovation and ensure patient outcomes. Explore our offerings: --Drug-Device Combinations: End-to-end solutions across formats like pen devices, autoinjectors, and pre-filled syringes --Complex Injectables: Expertise in the development and manufacturing of sterile liquids, lyophilized solids and dry powders, supporting advanced drug delivery systems --Biologics: End-to-end capabilities for development and manufacturing of biologics, across microbial and mammalian technology platforms --Softgel: Full-service manufacturing solutions for diverse formulations With global regulatory approvals and cutting-edge facilities, Stelis is your trusted partner for delivering high-quality healthcare solutions. Let’s meet and discuss how we can accelerate your product’s path to market. Visit us at Booth #5C33 | To schedule a meeting, write to us [email protected] #CPHI2024 #CDMO #Biologics #DrugDeviceCombinations #Softgel #StelisBiopharma #EndtoEndSolutions